The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Targeted genome editing in human repopulating haematopoietic stem cells
Open accessAbstract
Targeted genome editing by artificial nucleases has brought the goal of site-specific transgene integration and gene correction within the reach of gene therapy. However, its application to long-term repopulating haematopoietic stem cells (HSCs) has remained elusive. Here we show that poor permissiveness to gene transfer and limited proficiency of the homology-directed DNA repair pathway constrain gene targeting in human HSCs. By tailoring delivery platforms and culture conditions we overcame these barriers and provide stringent evidence of targeted integration in human HSCs by long-term multilineage repopulation of transplanted mice. We demonstrate the therapeutic potential of our strategy by targeting a corrective complementary DNA into the IL2RG gene of HSCs from healthy donors and a subject with X-linked severe combined immunodeficiency (SCID-X1). Gene-edited HSCs sustained normal haematopoiesis and gave rise to functional lymphoid cells that possess a selective growth advantage over those carrying disruptive IL2RG mutations. These results open up new avenues for treating SCID-X1 and other diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Nevertheless, the HDR pathway is not highly active in human cells, thus strongly limiting the clinical efficacy of this application23,24.”
From Allele specific repair of splicing mutations in cystic fibrosis through AsCas12a genome editing (2019) · cites this paper as [24]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Sequence Alignment/Map format and SAMtools
Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., Abecasis, G., Durbin, R., & 1000 Genome Project Data Processing Subgroup (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp352 · Cited by 62,041
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
Clustal W and Clustal X version 2.0
Larkin, M., Blackshields, G., Brown, N. P., Chenna, R., McGettigan, P., McWilliam, H., Valentin, F., Wallace, I. M., Wilm, A., López, R., et al. (2007) · Bioinformatics · doi:10.1093/bioinformatics/btm404 · Cited by 28,598
The DNA Damage Response: Making It Safe to Play with Knives
Ciccia, A., & Elledge, S. J. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.09.019 · Cited by 4,368
CRISPR-Cas systems for editing, regulating and targeting genomes
Sander, J. D., & Joung, J. K. (2014) · Nature Biotechnology · doi:10.1038/nbt.2842 · Cited by 3,153
Genome editing with engineered zinc finger nucleases
Urnov, F. D., Rebar, E. J., Holmes, M. C., Zhang, H. S., & Gregory, P. D. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2842 · Cited by 2,285
Self-citationA human memory T cell subset with stem cell–like properties
Gattinoni, L., Lugli, E., Ji, Y., Pos, Z., Paulos, C. M., Quigley, M. F., Almeida, J. R., Gostick, E., Yu, Z., Carpenito, C., et al. (2011) · Nature Medicine · doi:10.1038/nm.2446 · Cited by 1,974
TALENs: A widely applicable technology for targeted genome editing
Joung, J. K., & Sander, J. D. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3486 · Cited by 1,650 · cited 1×
“Artificial endonucleases, such as Zinc Finger Nucleases (ZFNs) 11 , Transcription Activator-Like Effector Nucleases (TALENs) 12 , and RNA-guided nucleases (CRISPR/Cas) 13 brought the possibility of gene targeting within the reach of gene therapy 14,15 .”
Highly efficient endogenous human gene correction using designed zinc-finger nucleases
Urnov, F. D., Miller, J. C., Lee, Y.-L., Beausejour, C. M., Rock, J. M., Augustus, S., Jamieson, A. C., Porteus, M. H., Gregory, P. D., & Holmes, M. C. (2005) · Nature · doi:10.1038/nature03556 · Cited by 1,642
Self-citationHematopoietic Stem Cell Gene Therapy with a Lentiviral Vector in X-Linked Adrenoleukodystrophy
Cartier, N., Hacein-Bey-Abina, S., Bartholomae, C. C., Veres, G., Schmidt, M., Kutschera, I., Vidaud, M., Abel, U., Dal-Cortivo, L., Caccavelli, L., et al. (2009) · Science · doi:10.1126/science.1171242 · Cited by 1,508 · cited 1×
“Hematopoietic Stem Cells (HSC)-based gene therapy has provided therapeutic benefit in primary immunodeficiencies 1,2 , thalassemia 3 and leukodystrophies 4,5 .”
Flagged first, then by citations
Cited by
Sorted by citations
Items 501–561 of 561
The EHA Research Roadmap: Hematopoietic Stem Cells and Allotransplantation
Fibbe, W., Bernardi, R., Charbord, P., Krause, D., Celso, C. L., Méndez-Ferrer, S., Mummery, C. L., Oostendorp, R. A. J., Raaijmakers, M., Socié, G., et al. (2022) · HemaSphere · doi:10.1097/hs9.0000000000000714 · Cited by 1
(2015) · Human Gene Therapy Clinical Development · doi:10.1089/humc.2015.2529 · Cited by 1
Gene Therapy for Severe Haemoglobin Disorders
Villamizar, O., Chambers, C. B., & Wilber, A. C. (2014) · Wiley eBooks · doi:10.1002/9780470015902.a0025829 · Cited by 1
Novel therapies in β- thalassemiaPreprint
Grech, L., Borg, K., & Borg, J. (2020) · doi:10.22541/au.159493426.68847455 · Cited by 1
Rai, R., Vetharoy, W., Naseem, A., Steinberg, Z., Thrasher, A. J., Santilli, G., & Cavazza, A. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.01.11.475795 · Cited by 1
The EHA Research Roadmap: Hematopoietic Stem Cells and Allotransplantation.
Fibbe, W. E., Bernardi, R., Charbord, P., Krause, D. S., Celso, C. L., Méndez‐Ferrer, S., Mummery, C. L., Oostendorp, R. A. J., Raaijmakers, M. H. G. P., Socié, G., et al. (2022) · Apollo (University of Cambridge) · doi:10.17863/cam.85212 · Cited by 1
Globin gene regulation for treating β-thalassemias: progress, obstacles and future
Saliba, A. N., Alameddine, R. S., Harb, A., & Taher, A. T. (2015) · Expert Opinion on Orphan Drugs · doi:10.1517/21678707.2015.1074071
Genome editing in haematopoietic stem cells
Koch, L. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3773
Calero-Garcia, M., & Gaspar, H. B. (2014) · Current Pediatrics Reports · doi:10.1007/s40124-014-0069-1
Computational Biology-Driven Genomic and Epigenomic Delineation of Acute Myeloid Leukemia
Sanders, M. A. (2015) · EUR Research Repository (Erasmus University Rotterdam)
Tolar, J. (2015) · Blood · doi:10.1182/blood-2015-03-633933
Genome editing and stem cell therapy pave the path for new treatment of sickle-cell disease.
Randolph, M. K., & Zhao, W. (2015) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2306-9759.2015.11.02
Barriers to Effective Genome Editing of Haematopoietic Stem Cells
Howe, S. J., & Milsom, M. D. (2016) · Current Stem Cell Reports · doi:10.1007/s40778-016-0032-x
Developing novel therapeutic strategies for Rett syndrome
Ross, P. D. (2016) · Enlighten: Theses (The University of Glasgow)
Gene Delivery Technologies for Efficient Genome Editing: Applications in Gene Therapy
Martín, F., Sánchez-Hernández, S., Gutiérrez-Guerrero, A., & Benabdellah, K. (2016) · InTech eBooks · doi:10.5772/62776 · Cited by 1
Primary Immunodeficiency Disorders: Diagnosis and Management
Maggina, P., & Gennery, A. R. (2016) · Springer eBooks · doi:10.1007/978-3-319-30352-9_49
Progress of genome editing approaches towards gene therapy
Ji, H., & Zhu, H. (2015)
Strategies for the Gene Modification of Megakaryopoiesis and Platelets
Latorre-Rey, L. J., & Modlich, U. (2016) · Springer eBooks · doi:10.1007/978-3-319-39562-3_20
Designer Effectors for Editing and Regulating Complex Genomes
Müller, M., Mlambo, T., & Mussolino, C. (2017) · Springer eBooks · doi:10.1007/978-3-319-53457-2_7
Zubia, G. R. (2009) · Hispana
Genomeditierung in der Zell- und Gentherapie
Pruszak, J., Müller, M., König, S., & Cathomen, T. (2017) · Transfusionsmedizin · doi:10.1055/s-0043-105031
Bibi, R. (2018) · Pure and Applied Biology · doi:10.19045/bspab.2018.70082
A súlyos kombinált immundefektusok újszülöttkori szűrővizsgálata
Erdös, M. (2018) · Orvosi Hetilap · doi:10.1556/650.2018.31106
Genome Editing Technologies: From Bench Side to Bedside
Tuncay, F. Y., & Dinçer, P. (2018) · Acta Medica · doi:10.32552/2018.actamedica.282
Gene Therapy for Nonmalignant Hematology
Wang, X., & Rivière, I. (2018) · Advances and controversies in hematopoietic transplantation and cell therapy · doi:10.1007/978-3-319-54368-0_14
Enhancing the Efficiency of CRISPR/Cas9 Precise Gene Editing for Cystic Fibrosis Gene Therapy
Seigel, K. E. (2018) · TSpace (University of Toronto)
Biomaterials for gene editing therapeutics
Shim, G., Kim, D., Le, Q., Byun, J., Park, J.-W., & Oh, Y. (2020) · Elsevier eBooks · doi:10.1016/b978-0-08-102983-1.00008-9
Genome editing tools and its potential applications in translational medicine- a brief overview.
Pillai, A. B., & Elanthiraiyan, S. (2016) · Annals of SBV · doi:10.5005/jp-journals-10085-5104
Roman‐Rodriguez, F. J., Ugalde, L., Alvarez, L. A., Díez, B., Risueño, C., Cortón, M., Bogliolo, M., Ayuso, C., Ramı́rez, M. J., Rodríguez, S., et al. (2018) · SSRN Electronic Journal · doi:10.2139/ssrn.3285807
Eguizábal, C., Herrera, L., Inglés‐Ferrándiz, M., & Belmonte, J. C. I. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02281-1
Modelling and genetic correction of liver genetic diseases
Zabulica, M. (2021) · Figshare
[Gene editing for the treatment of primary immunodeficiency disease].
Liu, S., Fang, S., & An, Y. (2021) · PubMed · doi:10.7499/j.issn.1008-8830.2103150
Gentherapie bei angeborenen Defekten der Immunität
Ghosh, S. (2022) · Kinder- und Jugendmedizin · doi:10.1055/a-1677-7644
Genome‐Editing Applications in Stem Cell Engineering and Regenerative Medicine
Gupta, P., Jaitly, S., Thakur, P., Goswami, S. G., Bhargava, N., & Ramalingam, S. (2022) · Wiley eBooks · doi:10.1002/9781119671404.ch17
Gene Therapy: Hemoglobinopathies
(2015) · Sage eBooks · doi:10.4135/9781483347660.n159
Gene therapy for primary immune deficiencies
Kohn, D. B. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-816768-7.00058-2
Aron, J. L., Thauland, T. J., Khan, H. A., & Butte, M. J. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.06.20.496920
Yang, F., Pang, J., Liu, G., Yang, Y., Qin, S., Zhang, Y., Lai, Y., Liang, D., & Wu, Y. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.09.05.506576
Genome Editing with CRISPR‐Cas Systems
Lotfy, P., & Hsu, P. D. (2022) · Wiley eBooks · doi:10.1002/9781683673798.ch11
Micco, R. D., della Volpe, L., Vacca, R., Midena, F., Tavella, T., Naldini, M. M., Barcella, M., Giannetti, K., Ferrari, S., Beretta, S., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-3192507/v1
Self-citationThe enhancement of CRISPR/Cas9 gene editing using metformin
Rollins, J. L., Hall, R. M., Lemus, C. J., Leisten, L. A., & Johnston, J. M. (2023) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2023.101539
Application of CRISPR-Cas12a technology in zebrafish to simulate ß-globin gene (HBB) mutationsPreprint
Shafique, F., Ali, S., Balckburn, E., & Hassan, M. U. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.09.21.558926
Gene therapy: advocacies, perspectives, and ethical provocations
Taliyan, R., Sukhija, R., Kothekar, A., Mishra, A., Nair, P. K. R., & Gurjar, S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91924-1.00013-7
George, A., Ravi, N. S., Vaishnavi, B., Marepally, S. K., Thangavel, S., Velayudhan, S. R., Srivastava, A., & Mohankumar, K. M. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.12.04.569931
Gene Editing Approaches for Haematological Disorders
Ferrari, S., & Canarutto, D. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15717-2.00053-6
Gene Expression and Editing in Mammalian Retinal Ganglion Cells
Tran, N. M., Xu, X., Qi, L. S., & Hu, Y. (2024) · Essentials in ophthalmology/Essentials ophthalmology · doi:10.1007/978-981-99-4436-1_19
Saksham, S., Venkatagiri, K., Hemangi, P., Gandhi, D. N., Estifanos, H., & Hussain, S. (2024) · InterConf · doi:10.51582/interconf.19-20.10.2024.026
Ho, C.-H., Chan, Y., Ho, C.-H., Tsai, C., Huang, C., Lu, Y.-C., Lu, Y.-C., Lin, C., Cheng, Y.-F., Lin, C.-H., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26114980
Hardouin, G., Martinucci, P., Scaramuzza, S., Antoniou, P., Corradi, F., Tachtsidi, A., Corre, G., Mombled, M., Manceau, S., Rouillon, C., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.08.21.671453
Gene Therapy for Inborn Errors of Immunity
Caetano-Silva, S. P., & Booth, C. (2025) · Wiley eBooks · doi:10.1002/9780470015902.a0029694
Future perspective of nanoparticles in gene delivery and gene therapy
Naghib, S. M., Kashani, G. K., Shamaeizadeh, A., & Mahdavi, H. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-31490-2.00009-5
Grockowiak, É. (2017) · theses.fr (ABES) · doi:10.70675/600cdac6za637z42abz900fzf78b400f9638
New therapeutic strategies for the treatment of β-hemoglobinopathies
Weber, L. (2018) · theses.fr (ABES) · doi:10.70675/09314463zdfd1z46b4z9c0cz32c6c2c5ccc2
Génotoxicité des systèmes CRISPR-Cas9.
Cullot, G. (2019) · theses.fr (ABES) · doi:10.70675/cb1809e4zaafbz4fc1z89e9zeb0e5fd69275
Base editing approaches for the treatment of ß-hemoglobinopathies
Hardouin, G. (2022) · theses.fr (ABES) · doi:10.70675/593cd291z9d0ez45a6z82cdz64ffb2e65ff8
CRISPR-Cas9-based strategies for enhanced targeted integration
Lacombe, L. (2024) · theses.fr (ABES) · doi:10.70675/9c9d279dz512az4b72z8322zea205cef9b67
Kuo, C. Y., Harrington, S., Campo-Fernández, B., Wyman, S. K., Wu, X., Zhang, R., Espinoza, A., Silva, B. J. D. A., Sanchez, J. M., Fitz‐Gibbon, S. T., et al. (2026) · Stem Cell Research & Therapy · doi:10.1186/s13287-026-05010-8
Advancing Hematopoietic Stem Cell Research: The Impact of Bioengineered 3D Bone Marrow Niches
Sidharthan, H. K., Goel, M., Unni, M., Sidharthan, N., & Sathy, B. N. (2026) · Stem Cell Reviews and Reports · doi:10.1007/s12015-026-11128-2
Primary Immunodeficiency Disorders
Gennery, A. R. (2026) · Springer eBooks · doi:10.1007/978-3-032-13858-3_50
Metadata
- Authors
- Genovese, P., Schiroli, G., Escobar, G., Di Tomaso, T., Firrito, C., Calabria, A., Moi, D., Mazzieri, R., Bonini, C., Holmes, M. C., Gregory, P. D., van der Burg, M., Gentner, B., Montini, E., Lombardo, A., & Naldini, L.
- Affiliations
- The San Raffaele Telethon Institute for Gene Therapy (IT)
- Vita-Salute San Raffaele University (IT)
- IRCCS Ospedale San Raffaele (IT)
- Sangamo BioSciences (United States) (US)
- Erasmus MC (NL)
- Corresponding author
- Naldini, Luigi
- ORCID
- Venue
- Nature
- Published
- 2014-05-28
- Volume
- 510
- Issue
- 7504
- Pages
- 235-240
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4082311
- OpenAlex
- W1995497292
- Cited by
- 555
- References
- 44
- Citations by year
- 2026: 7 · 2025: 20 · 2024: 23 · 2023: 32 · 2022: 42 · 2021: 51 · 2020: 43 · 2019: 50 · 2018: 57 · 2017: 57 · 2016: 71 · 2015: 77 · 2014: 24
- FWCI
- 28.82
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
- PubMed Central (acceptedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
- RePEc: Research Papers in Economics (submittedVersion)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Keywords
- targeted genome editing, hematopoietic stem cells, homology-directed repair, gene targeting, IL2RG, X-linked severe combined immunodeficiency, gene therapy, transgene integration
- MeSH terms
- Animals, Endonucleases, Fetal Blood, Hematopoiesis, Hematopoietic Stem Cells, Humans, Male, Mutation, Genome, Human, DNA, Complementary, Hematopoietic Stem Cell Transplantation, Gene Targeting, Antigens, CD34, Mice, Targeted Gene Repair, Interleukin Receptor Common gamma Subunit, X-Linked Combined Immunodeficiency Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
